Tumor stem cells and malignant multicellular networks have been separately implicated in the therapeutic resistance of glioblastoma multiforme (GBM), the most aggressive type of brain cancer in adults. Here, we show that small-molecule inhibition of RHO-associated serine/threonine kinase proteins (ROCKi) significantly promoted the outgrowth of neurite-like cell projections in cultures of heterogeneous patient-derived GBM stem-like cells. These projections formed de novo-induced cellular network (iNet) ‘webs’, which regressed after withdrawal of ROCKi. Connected cells within the iNet web exhibited long range Ca2+ signal transmission, and significant lysosomal and mitochondrial trafficking. In contrast to their less-connected vehicle control counterparts, iNet cells remained viable and proliferative after high-dose radiation. These findings demonstrate a link between ROCKi-regulated cell projection dynamics and the formation of radiation-resistant multicellular networks. Our study identifies means to reversibly induce iNet webs ex vivo, and may thereby accelerate future studies into the biology of GBM cellular networks.

GBM is the most frequent malignant primary brain tumor in adults and despite multimodality treatment, prognosis remains poor (Davis, 2016; Grossman and Batara, 2004). Five-year survival is <5% (Ostrom et al., 2014) and, despite surgical removal of the tumor bulk, GBM often recurs from residual tumor cells surviving radiation and chemotherapy (Osuka and Van Meir, 2017). The cellular response to these treatments likely involves the cytoskeleton, a key organizer of cell and organelle function, movement, and shape (Fletcher and Mullins, 2010). However, the molecular mechanisms underlying cytoskeletal dynamics in GBM cells remain largely elusive.

The RHO-associated serine/threonine kinase (ROCK) family plays a central role in the regulation of actin cytoskeletal dynamics (Sanz-Moreno et al., 2011). The ROCK family comprises the ROCK1 and ROCK2 proteins phosphorylating diverse downstream substrates that regulate actin filament stabilization and myosin-driven contraction (Maekawa et al., 1999; Ohashi et al., 2000; Rath and Olson, 2012). Accordingly, ATP-competitive small-molecule inhibitors have been used to study the role of ROCK1 and ROCK2 in cells, and chemical pan-ROCK inhibition (hereinafter referred to as ROCKi) has been considered as a potential anti-tumor therapeutic strategy (Rath and Olson, 2012). While ROCKi promotes morphological changes in neural stem cells (Jia et al., 2016), axonal outgrowth and neuroprotection (Dergham et al., 2002; Fournier et al., 2003; Fujita and Yamashita, 2014), conflicting pro- and anti-tumor effects have been reported in various cancer cell types (Salhia et al., 2005; Tilson et al., 2015; Zohrabian et al., 2009).

We hypothesized that ROCKi-dependent cytoskeletal rearrangements may affect the GBM cellular phenotype. We observed that ROCKi robustly induced the elongation of GBM cell projections that were morphologically akin to neurites. Furthermore, we investigated the impact of these cell projections on cellular connectivity and cooperation using mathematical and experimental network analysis and examined multicellular network function in regards to a potential for promoting radiation resistance (Winkler and Wick, 2018; Osswald et al., 2015; Weil et al., 2017).

ROCKi leads to neurite-like projection elongation in GBM cell models

We phenotypically characterized chemical ROCK inhibition in transcriptionally heterogeneous patient-derived GBM cell lines (GBM1, GBM4, GBM11, GBM13 and GBM20) that represent different GBM subtypes (Polson et al., 2018). We used adherent culture conditions, which conserved their stem cell-like characteristics (da Silva et al., 2018; King et al., 2017; Polson et al., 2018; Wurdak, 2012; Wurdak et al., 2010), and ROCKi Y-27632, a biochemical tool for ROCK investigation (Rath and Olson, 2012). After stimulation of the RhoA/ROCK pathway in GBM1 cells with lysophosphatidic acid (LPA; 1 μM), Y-27632 (20 µM) significantly reduced the level of phosphorylated ROCK downstream effector protein myosin phosphatase target subunit 1 (MYPT1, also known as PPP1R12A) after 30 min at Thr853 (Garton et al., 2008) as compared to the vehicle (H2O) control (Fig. S1A; phosphorylated MYPT1 protein levels partially recovered after 4 h suggesting compensatory upstream signaling). Time lapse microscopy of five different GBM cell models with 20 µM Y-27632 revealed a pronounced rapid elongation of cellular projections akin to cytokine-stimulated neurite outgrowth (Drubin et al., 1985) (Movies 1 and 2). We determined the change in cellular projection length (CPL) for 21 randomly-selected individual cells per GBM cell model by subtracting the total projection lengths at time 0 (t0) from the values obtained for the same cells 24 h after vehicle- or Y-27632 treatment. In the presence of Y-27632, the CPL was significantly elevated in all tested GBM cell models [compared to the vehicle (H2O) controls; P≤0.0002; Fig. 1A]. Projections stained positive for the neuron-specific neurite markers class III β-tubulin (TuJ1, also known as TUBB3) and microtubule-associated protein 2 (MAP2) (Fig. 1B), which is expressed in both low- and high-grade diffuse brain tumors (Wharton et al., 2002). Maximal CPL values were reached after a treatment period of ∼24 h (Fig. S1B,C). Expression of TuJ1 and MAP2 remained unaltered, indicating redistribution of cell body neurofilaments into the elongating projections (Fig. S1D).

Fig. 1.

Chemical ROCK inhibition elongates CPL in patient-derived GBM cell models. (A) Dots are changes in CPL (µm; t24t0 values) of 21 individually traced cells per indicated GBM cell line treated with vehicle (H2O) or Y-27632 (20 μM). Plots indicate the median with 95% confidence intervals. (B) Immunocytochemistry images of projections (indicated by arrowheads) in vehicle (H2O)- or Y-27632 (20 μM)-treated GBM1 cells stained for MAP2 and TuJ1. Scale bar: 200 µm. (C) Dots are mean±s.d. TuJ1- and MAP2-positive CPL values of independent experiments at 24 h after vehicle (H2O) or Y-27632 (20 μM) treatments using the indicated cell models (∼200 cells analyzed per treatment). (D) Data are mean±s.d. CPL values of independent experiments (black lines, median) in presence of vehicle (H2O) or the indicated small-molecule inhibitors. (E) Dots are mean±s.d. CPL values of independent experiments following 24 h pre-treatment with Y-27632 (20 μM), and a subsequent 8-h treatment with vehicle (blue bar), LPA (1 μM, purple bar), LPA (1 μM) plus Y-27632 (20 μM, orange bar), or Y-27632 (20 μM, red bar); ∼200 cells analyzed per treatment. (F) Left, representative images of GBM1 cells following a 16-h period in Matrigel with vehicle (H2O) or Y-27632 (20 μM) treatments. Arrowheads depict neurite-like outgrowth. Scale bar: 20 µm. Right, data are mean±s.d. CPL values of independent experiments (>260 cells analyzed per indicated treatment). The P-values were determined by Mann–Whitney U-test (two-tailed; A), Student's t-test (two-tailed, equal variance; C) or one-way ANOVA (D–F). n.s., not significant.

Fig. 1.

Chemical ROCK inhibition elongates CPL in patient-derived GBM cell models. (A) Dots are changes in CPL (µm; t24t0 values) of 21 individually traced cells per indicated GBM cell line treated with vehicle (H2O) or Y-27632 (20 μM). Plots indicate the median with 95% confidence intervals. (B) Immunocytochemistry images of projections (indicated by arrowheads) in vehicle (H2O)- or Y-27632 (20 μM)-treated GBM1 cells stained for MAP2 and TuJ1. Scale bar: 200 µm. (C) Dots are mean±s.d. TuJ1- and MAP2-positive CPL values of independent experiments at 24 h after vehicle (H2O) or Y-27632 (20 μM) treatments using the indicated cell models (∼200 cells analyzed per treatment). (D) Data are mean±s.d. CPL values of independent experiments (black lines, median) in presence of vehicle (H2O) or the indicated small-molecule inhibitors. (E) Dots are mean±s.d. CPL values of independent experiments following 24 h pre-treatment with Y-27632 (20 μM), and a subsequent 8-h treatment with vehicle (blue bar), LPA (1 μM, purple bar), LPA (1 μM) plus Y-27632 (20 μM, orange bar), or Y-27632 (20 μM, red bar); ∼200 cells analyzed per treatment. (F) Left, representative images of GBM1 cells following a 16-h period in Matrigel with vehicle (H2O) or Y-27632 (20 μM) treatments. Arrowheads depict neurite-like outgrowth. Scale bar: 20 µm. Right, data are mean±s.d. CPL values of independent experiments (>260 cells analyzed per indicated treatment). The P-values were determined by Mann–Whitney U-test (two-tailed; A), Student's t-test (two-tailed, equal variance; C) or one-way ANOVA (D–F). n.s., not significant.

Y-27632-treated cells consistently exhibited a marked CPL elongation in three different GBM cell models (Fig. 1C). The structurally distinct ROCK inhibitors H1152 (10 µM; Ikenoya et al., 2002) and GSK269962 (5 μM; Doe et al., 2007) recapitulated the Y-27632 effect in GBM1 cells (P<0.0001; Fig. 1D), linking ROCKi and the cellular phenotype. Two different downstream effectors of ROCK were disrupted using Blebbistatin, an inhibitor of the non-muscle myosin II protein (NM II; Straight et al., 2003), and LIM domain kinase inhibitor 3 (LIMKi3), a suppressor of LIMK-dependent cofilin phosphorylation (Ross-Macdonald et al., 2008). Blebbistatin (2.5 μM) markedly increased the CPL (P<0.0001), whereas LIMKi3 (5 μM) had little (a control-like) effect, thus suggesting that disruption of ROCKi activation of NM II, rather than LIMK protein was relevant for the observed CPL elongation (Fig. 1D). GBM1 cell exposure to LPA (1 μM, 8 h), which induces neurite retraction in neuronal cells (Kranenburg et al., 1999), did not reduce the CPL in presence of Y-27632 (Fig. 1E). Furthermore, culture of GBM cells in Matrigel, an extracellular matrix-based hydrogel, which can promote tube formation in cell lines (Francescone et al., 2011), was unable to mask the Y-27632-induced effect on neurite-like outgrowth (Fig. 1F).

A de novo-induced network phenotype in GBM cells

To determine whether the ROCKi-induced projection elongations enabled an integrated multicellular system, we used mathematical network analysis through mapping GBM1 cell bodies and protrusions under the assumption that they are connected objects, equivalent to nodes and edges in a discrete network (Jackson et al., 2017) (Fig. 2A). In contrast to the control cell phenotype (hereinafter referred to as Con), the logical network topology indicators ‘degree and betweenness centrality’ (Newman, 2006) were significantly elevated in the Y-27632-treated cells (Fig. 2B), hence indicating a de novo-induced cellular network (hereinafter referred to as iNet). The iNet formation was accompanied by a marked decrease in cellular motility under >50% confluency, whereas motility remained unaltered when intercellular contact was minimal (<10% confluency; Fig. 2C). Moreover, iNet cells retracted their projections within 8 h of ROCKi withdrawal, demonstrating reversion of the cell ‘web’ phenotype (hereinafter referred to as Rev) (Fig. 2D; Fig. S1E). Time lapse microscopy (Fig. 2E), clonal cell growth analysis (Fig. S1F) and Ki67 staining (Fig. 2E; Fig. S2A), indicated comparable proliferation capacities for Con, iNet and Rev GBM1 cells. In addition, RNA-seq transcriptional comparison of iNet and Rev cellular profiles revealed the protein AMIGO3 (adhesion molecule with Ig like domain 3), an inhibitor of axonal growth (Ahmed et al., 2013), as the most downregulated iNet-associated transcript (Fig. 2F). Further analysis using the database for annotation, visualization and integrated discovery (DAVID; Huang et al., 2009a,b) and gene set enrichment analysis (GSEA; Subramanian et al., 2005) suggested iNet-specific enrichment of axonal guidance-regulating genes (Fig. S2B,C), and positive iNet signature correlations with cell projection growth, cytoskeletal organization, cell cycle progression and anti-apoptotic pathways (Fig. 2G).

Fig. 2.

Chemically induced de novo network formation in GBM cells. (A) Representative topologies of vehicle control (Con; left) or Y-27632-induced GBM1 cell networks (iNet, right). (B) Con versus iNet network modal degree (left) and betweenness (right) values of independent experiments. (C) Data are individual GBM1 cell movement distances under indicated confluency and treatment. The box represents the 25–75th percentiles, and the median is indicated. The whiskers show the complete range. (D) Data are mean±s.d. CPL values of independent experiments using Con, iNet or Rev (Y-27632 ‘washout’) conditions (∼200 cells analyzed per condition). (E) Left, real-time assessment of GBM1 Con, iNet or Rev cell confluency (fold change normalized to that at t0). One out of three independent experiments is shown. Right, mean±s.d. percentages of Ki67-expressing Con, iNet or Rev cells (three independent experiments; >1500 cells analyzed per condition). (F) Volcano plot comparing transcriptional RNA-seq profiles of genes in iNet versus Rev conditions in GBM1 cells passing a threshold false discovery rate (FDR) of <5% (indicated by red color) based on three independent experiments. The log2 fold change expression is shown and negative values indicate genes showing a decrease in expression in iNet compared to Rev conditions. (G) GSEA plots of ranked gene expression (FDR <5%) comparing transcriptional iNet and Rev profiles and their positive (red) and negative (blue) correlations for the indicated gene sets. Enrichment scores are shown as green lines, and the horizontal black bars indicate the position of the associated genes for each enrichment set. The P-values were determined by the Mann–Whitney U-test (one-tailed; B) and one-way ANOVA (C,D).

Fig. 2.

Chemically induced de novo network formation in GBM cells. (A) Representative topologies of vehicle control (Con; left) or Y-27632-induced GBM1 cell networks (iNet, right). (B) Con versus iNet network modal degree (left) and betweenness (right) values of independent experiments. (C) Data are individual GBM1 cell movement distances under indicated confluency and treatment. The box represents the 25–75th percentiles, and the median is indicated. The whiskers show the complete range. (D) Data are mean±s.d. CPL values of independent experiments using Con, iNet or Rev (Y-27632 ‘washout’) conditions (∼200 cells analyzed per condition). (E) Left, real-time assessment of GBM1 Con, iNet or Rev cell confluency (fold change normalized to that at t0). One out of three independent experiments is shown. Right, mean±s.d. percentages of Ki67-expressing Con, iNet or Rev cells (three independent experiments; >1500 cells analyzed per condition). (F) Volcano plot comparing transcriptional RNA-seq profiles of genes in iNet versus Rev conditions in GBM1 cells passing a threshold false discovery rate (FDR) of <5% (indicated by red color) based on three independent experiments. The log2 fold change expression is shown and negative values indicate genes showing a decrease in expression in iNet compared to Rev conditions. (G) GSEA plots of ranked gene expression (FDR <5%) comparing transcriptional iNet and Rev profiles and their positive (red) and negative (blue) correlations for the indicated gene sets. Enrichment scores are shown as green lines, and the horizontal black bars indicate the position of the associated genes for each enrichment set. The P-values were determined by the Mann–Whitney U-test (one-tailed; B) and one-way ANOVA (C,D).

The iNet phenotype increases GBM multicellular cooperation

To test whether iNet promoted multicellular cooperation, we assessed Ca2+ and fluorescent dye transmission in GBM1 cells (Fig. 3A,B). Upon focused laser stimulation, fluorescence indicator of intracellular calcium 3 (Fluo-3; Minta et al., 1989) signal intensity increased in the neighboring cells, and maximum intensities were markedly elevated in iNet compared to Con cells (P=0.012; Fig. 3C). Less than 40% of Con cells participated in the Fluo-3 transmission waves, with Fluo-3 signal angles ranging between 60° and 320° (Fig. 3D). In contrast, ∼80% of iNet cells participated in the Ca2+ signal extensions exhibiting angles of >320° (Fig. 3D). In addition, scrape-loading dye transfer experiments (el-Fouly et al., 1987) showed a significant increase in the cell-to-cell transfer of Lucifer Yellow in iNet compared to Con conditions (>2-fold, P=0.005; Fig. 3E), thus indicating gap junction-mediated cell-to-cell communication. Furthermore, confocal time lapse imaging revealed significant localization and trafficking of lysosomes and mitochondria into iNet cell projections, which was limited by the lack of neurite-like elongations in Con cells (Fig. 3F,G; Movies 3–6). We next carried out GBM1 co-culture (1:1) experiments with MitoTracker-labeled mitochondrial ‘donor’ and GFP-expressing ‘recipient’ cells (harboring unlabeled mitochondria). After 24 h, the transfer of labeled mitochondria into recipient cells was significantly increased (≥2-fold) by iNet in a cell density-dependent fashion (Fig. 3H,I). These results demonstrate an intercellular physical connection beyond mitochondrial trafficking to the cortical cytoskeleton, which has been shown to promote tumor cell motility/invasion (Caino et al., 2013) and metastasis (Caino et al., 2016).

Fig. 3.

The iNet phenotype promotes multicellular cooperation. (A) Still-frame images of intracellular Fluo-3 transmission upon laser irradiation of a single Con or iNet GBM1 cell (indicated by arrowheads). Scale bar: 30 μm. (B) False-color image of Lucifer Yellow dye transfer using scrape loading technique in Con or iNet cells. Scale bar: 50 μm. (C) Data are mean±s.d. of Fluo-3 signal intensities of independent (pre- and post-laser) experiments using Con or iNet conditions. (D) Left, mean±s.d. percentages of independent (post-laser) experiments assessing total Con or iNet cells transmitting the Fluo-3 wave. Right, mean±s.d. wave transmission angle values per imaged field in independent experiments. (E) Mean±s.d. percentages of independent experiments assessing the transfer of Lucifer Yellow between cells (>500 cells were analyzed per Con or iNet condition). (F) Mean±s.d. percentages of independent experiments (dots) assessing lysosomal and mitochondrial signals within Con or iNet cell projections. (G) Dots represent migration distances of four individually traced mitochondria per four independent imaging experiments in Con or iNet cells, and overall results as mean±s.d. (H) Values are the mean±s.d. percentages of independent experiments assessing MitoTracker-positive signals within GFP-expressing Con or iNet ‘recipient’ cells per indicated cell seeding density (>90 cells analyzed per condition). (I) Confocal microscopy images of ‘donor’ (GBM1 MitoTracker-positive) and ‘recipient’ (GBM1 GFP-positive) Con or iNet cells with the indicated staining. The arrowhead depicts transferred mitochondria. Scale bar: 20 μm. The P-values were determined by the Mann–Whitney U-test (one-tailed) except for (H) where two-way ANOVA was used. n.s., not significant.

Fig. 3.

The iNet phenotype promotes multicellular cooperation. (A) Still-frame images of intracellular Fluo-3 transmission upon laser irradiation of a single Con or iNet GBM1 cell (indicated by arrowheads). Scale bar: 30 μm. (B) False-color image of Lucifer Yellow dye transfer using scrape loading technique in Con or iNet cells. Scale bar: 50 μm. (C) Data are mean±s.d. of Fluo-3 signal intensities of independent (pre- and post-laser) experiments using Con or iNet conditions. (D) Left, mean±s.d. percentages of independent (post-laser) experiments assessing total Con or iNet cells transmitting the Fluo-3 wave. Right, mean±s.d. wave transmission angle values per imaged field in independent experiments. (E) Mean±s.d. percentages of independent experiments assessing the transfer of Lucifer Yellow between cells (>500 cells were analyzed per Con or iNet condition). (F) Mean±s.d. percentages of independent experiments (dots) assessing lysosomal and mitochondrial signals within Con or iNet cell projections. (G) Dots represent migration distances of four individually traced mitochondria per four independent imaging experiments in Con or iNet cells, and overall results as mean±s.d. (H) Values are the mean±s.d. percentages of independent experiments assessing MitoTracker-positive signals within GFP-expressing Con or iNet ‘recipient’ cells per indicated cell seeding density (>90 cells analyzed per condition). (I) Confocal microscopy images of ‘donor’ (GBM1 MitoTracker-positive) and ‘recipient’ (GBM1 GFP-positive) Con or iNet cells with the indicated staining. The arrowhead depicts transferred mitochondria. Scale bar: 20 μm. The P-values were determined by the Mann–Whitney U-test (one-tailed) except for (H) where two-way ANOVA was used. n.s., not significant.

The iNet phenotype promotes survival of GBM cells post radiation

To test whether iNet increased cellular stress resistance, we irradiated iNet, Con and Rev GBM1 cells with 0, 2, 8 or 20 Gy, which resulted in a dose-dependent increase in DNA double-strand breaks as assessed by γH2AX staining (Kuo and Yang, 2008) (Fig. S3A,B). In contrast to Con and Rev cells, the irradiated iNet cells exhibited a marked increase in cellular projection outgrowth (Fig. S3C), and proliferation/survival rates, which were corroborated by live-cell confluency measurements (Fig. 4A), and cell fate analysis (tracing 15 individual cells per Con, Rev and iNet condition using time lapse microscopy; Fig. S3D). Consistently, nuclear fragmentation was significantly reduced 5 days after radiation (2, 8 and 20 Gy) in iNet compared with Con and Rev cells (>2-fold; P<0.001; Fig. 4B). Concomitantly, a dose-dependent increase in cytoplasmic swelling was observed in Con and Rev but not iNet cells (Fig. 4C).

Fig. 4.

iNet increases cellular radiation resistance. (A) Real-time assessment of GBM1 cell confluency (fold change normalized to t0) in Con, iNet or Rev GBM1 cells upon irradiation with the indicated doses. One out of three biological replicates is shown. (B) Left, images of fragmented nuclei (indicated by arrowheads) in Con, Rev or iNet GBM1 cells 5 days after irradiation. Scale bar: 20 μm. Right, bars are mean±s.d. percentages of cells with fragmented nuclei of three independent experiments using the indicated radiation doses (≥500 cells analyzed per condition). (C) Bars depict the means of GBM1 nuclear:cytoplasmic (N/C) ratios of total nuclear and cytoplasmic area per cell determined for three independent experiments (±s.d.) in Con, Rev, or iNet cells 5 days after irradiation with the indicated doses. (D) Data are means of independent cell viability experiments in Con, Rev or iNet cells 5 days after irradiation with the indicated doses, relative to the non-irradiated control. The box represents the 25–75th percentiles, and the median is indicated. The whiskers show the complete range. (E) Mitochondrial bioenergetic (extracellular flux) analysis of GBM1 cells 5 days after 20 Gy irradiation. OCR, oxygen consumption rate; O, oligomycin addition; F, FCCP addition; A/R, Antimycin and Rotenone addition. Data are the mean±s.d. of three biological replicates. The P-values were determined by one-way ANOVA (A,B,E) or two-way ANOVA (C,D) tests. n.s., not significant.

Fig. 4.

iNet increases cellular radiation resistance. (A) Real-time assessment of GBM1 cell confluency (fold change normalized to t0) in Con, iNet or Rev GBM1 cells upon irradiation with the indicated doses. One out of three biological replicates is shown. (B) Left, images of fragmented nuclei (indicated by arrowheads) in Con, Rev or iNet GBM1 cells 5 days after irradiation. Scale bar: 20 μm. Right, bars are mean±s.d. percentages of cells with fragmented nuclei of three independent experiments using the indicated radiation doses (≥500 cells analyzed per condition). (C) Bars depict the means of GBM1 nuclear:cytoplasmic (N/C) ratios of total nuclear and cytoplasmic area per cell determined for three independent experiments (±s.d.) in Con, Rev, or iNet cells 5 days after irradiation with the indicated doses. (D) Data are means of independent cell viability experiments in Con, Rev or iNet cells 5 days after irradiation with the indicated doses, relative to the non-irradiated control. The box represents the 25–75th percentiles, and the median is indicated. The whiskers show the complete range. (E) Mitochondrial bioenergetic (extracellular flux) analysis of GBM1 cells 5 days after 20 Gy irradiation. OCR, oxygen consumption rate; O, oligomycin addition; F, FCCP addition; A/R, Antimycin and Rotenone addition. Data are the mean±s.d. of three biological replicates. The P-values were determined by one-way ANOVA (A,B,E) or two-way ANOVA (C,D) tests. n.s., not significant.

Analysis of the iNet cells confirmed that the vast majority of nuclear fragmentation (≥88%) appeared outside of the multicellular networks and within a cellular subpopulation (<5% of total cells) that remained unconnected (Fig. S4A). Luminescent cell viability assays indicated a marked sustainability of iNet cell survival/proliferation after 8 and 20 Gy radiation doses. In agreement with glioma stem cell-associated radioresistance (Bao et al., 2006), only high-dose radiation (20 Gy) reduced GBM1 cell survival in Con and Rev conditions by ∼50%, whereas the iNet cells remained viable (P=0.0072; Fig. 4D). Furthermore, mRNA-seq transcriptional profiling and GSEA comparing Rev and iNet cells post 20 Gy irradiation suggested positive iNet signature correlations with the ‘mitotic cell cycle’, ‘negative regulation of cell death’, ‘P53’, ‘hypoxia’ and ‘oxidative stress’ pathways (Fig. S4B). Consistent with the latter being an expected consequence of ionizing radiation (Azzam et al., 2012), extracellular flux analysis 5 days after high-dose radiation (20 Gy) showed that the basal oxygen consumption rate (OCR) and the OCR following mitochondrial stress test were significantly elevated in iNet compared to Con and Rev conditions (Fig. 4E). This indicates an iNet phenotype-mediated ability of GBM cells to maintain their oxidative metabolism after radiation-induced stress.

In conclusion, our results show that ROCKi significantly promotes the outgrowth of cell projections in a spectrum of GBM stem-like models, which in turn enabled the de novo formation of cooperating multicellular networks. GBM stem-like cells have been shown to form interconnected networks through vasculogenic tubular structures (known as vasculogenic mimicry) based on endothelial-like differentiation in Matrigel (El Hallani et al., 2010). However, we observed rapid evolvement of neurite-like networks via ROCKi treatment which was distinct from GBM cellular differentiation/trans-differentiation (Piccirillo et al. 2006; Wurdak et al., 2010; El Hallani et al., 2010). The iNet formation was characterized by chemical reversibility, unaltered proliferation and a gene expression profile of cytoskeletal rearrangement implicating axonal outgrowth pathways. This induction of a reversible phenotypic switch for cellular networking may aid in the elucidation of intermittent cytoskeletal dynamics, and the exchange of cellular materials including mitochondria. Intercellular communication and mitochondrial transfer have been linked to increased cellular stress resistance and proliferation (Osswald et al., 2015; Torralba et al., 2016). Accordingly, iNet phenotypes may aid discovery and validation of radiosensitization targets in poorly differentiated GBM cells. Further investigations may shed light onto the mechanistic link between ROCKi and GBM cell network morphologies and their organelle trafficking, as well as tumor-promoting functions.

Cell culture

The patient-derived GBM cell models were established and characterized as described previously (Polson et al., 2018; Wurdak et al., 2010). The GBM1 (classical/proneural GBM subtype), GBM4 (mesenchymal GBM subtype), GBM11 (mesenchymal GBM subtype), GBM13 (proneural GBM subtype) and GBM20 (proneural/mesenchymal GBM subtype) cell lines represent a spectrum of transcriptionally heterogeneous primary and recurrent tumors (Polson et al., 2018). All these cell models maintain stem cell-like characteristics under adherent culture conditions, hence allowing for the rapid quantification of cellular responses to chemical perturbations (da Silva et al., 2018; King et al., 2017; Polson et al., 2018; Wurdak, 2012; Wurdak et al., 2010). The cells were adherently propagated on plasticware coated with poly-L-ornithin (5 μg/ml, Sigma, P3655) and laminin (5 mg/ml, Invitrogen, 23017-015). The cells were cultured in neurobasal medium (Gibco, 21103-049) supplemented with B27 (0.5×, Invitrogen, 17504-044), N2 (0.5×, Invitrogen, 17502-048), recombinant human basic fibroblast growth factor (40 ng/ml, bFGF, Gibco, PHG0024) and epidermal growth factor (40 ng/ml, EGF, R&D systems, 236-EG). Cells were maintained in a humidified incubator with 5% CO2 at 37°C.

Small-molecule inhibitor treatments

For small-molecule inhibitor cell profiling, a seeding density of 20,000 cells per cm2 was used and small-molecule inhibitor treatments started post cell adhesion (overnight). The ROCK pathway inhibitors Y-27632 (20 μM, Sigma, Y0503), H1125 (10 μM, Tocris, 2141), GSK 269962 (5 μM, Tocris, 4009), Blebbistatin (2.5 μM, Tocris, 1853) and LIM kinase inhibitor (LIMKi3, a kind gift from Michael Olson, Ryerson University, Toronto, Ontario, Canada; 5 μM) were added for 24 h. For compound withdrawal (‘washout’) experiments, cells were treated with distinct ROCK pathway inhibitors for the indicated period, followed by the removal of the treatment-containing medium (washing the cells with PBS) and subsequent addition of medium lacking the small-molecule inhibitors. Cells were assessed 8 h post compound ‘washout’.

Live-cell imaging and cell confluency measurements

Live-cell imaging was performed using GBM1 cells as previously described (Polson et al., 2018). Cells were seeded at a density of 20,000 cells per cm2. Cells were treated with vehicle (H2O) or Y-27632 (20 μM) and observed/recorded using the IncuCyte ZOOM® live-cell imaging system (Essen Bioscience).

For cellular projection length (CPL) measurements, projections of random cells were measured at t0. Cells were then individually tracked for 24 h, after which the projections were measured again. CPL values were obtained by subtracting the measured length at t0 from the length at t24 (24 h). For cells showing an increase in projection length after 24 h, this results in a positive CPL value, whereas a reduction in projection length results in a negative CPL value.

For confluency/growth curve analysis, the IncuCyte ZOOM® Confluence Processing analysis tool was used. For each condition, images were acquired longitudinally at set time points (t0, t25, t50, t100, t150; 25 h, 50 h, 100 h and 150 h, respectively), and these images were further processed by the IncuCyte ZOOM® Confluence Processing tool to quantify the increase in cellular density over background in each analyzed condition.

Clonal cell growth assay

Cells were seeded at a density of 150 cells/well into 24-well plates and allowed to adhere for 24 h. The next day, the single cells in each well were identified and counted. Treatments were carried for 7 days using vehicle (H2O) or Y-27632 (20 μM) or a compound ‘washout’ condition (via medium change after 16 h of Y-27632 treatment). On day 3 all media were refreshed sustaining the distinct conditions until experimental endpoint at day 7. The number of clonally derived colonies consisting of more than four cells was determined by phase-contrast microscopy.

Immunostaining

Cells were fixed with 4% (w/v) paraformaldehyde (PFA, Sigma, P6148) for 10 min and blocking was carried out for 1 h at room temperature with staining buffer (10% FBS in PBS) supplemented with 0.03% (v/v) Triton X-100 (Sigma, T8787). Next, the cells were incubated at 4°C overnight in staining buffer with the following primary antibodies: anti-neuronal class III β-tubulin (TuJ1, 1:300, Covance, 801202), anti-microtubule-associated protein 2 (MAP2, 1:1000, Abcam, ab5392), anti-Ki67 (1:200, Abcam, ab16667) and anti-phospho-H2AX (γH2AX, 1:800, Merck, JBW130). The cells were then incubated in staining buffer for 1 h in the dark at room temperature with the following secondary antibodies: goat anti-mouse IgG conjugated to Alexa Fluor 488 (1:500, Life Technologies, A11029); goat anti-chicken IgG conjugated to Alexa Fluor (1:500, Life Technologies, A21449) or Cy3 (1:500, Jackson ImmunoResearch, 711-165-152). The fluorescence signal was detected using an EVOS digital inverted fluorescence microscope or a Nikon A1R confocal microscope.

Immunoblotting

Whole-cell extracts were prepared by harvesting cells either in Laemmli sample buffer supplemented with 10 mM sodium fluoride, 1 mM sodium vanadate, 10 mM sodium β-glycerophosphate, 0.5 mM PMSF and Complete EDTA-free protease inhibitor (Roche), or in cell lysis buffer (Cell Signaling, 98035) supplemented with 1 mM PMSF (Cell Signaling, 8553). Samples were sonicated for 15 s prior to centrifugation (14,000 rpm for 20 min at 4°C). Lysates were then loaded onto Mini-Protean TGX precast gels (4–15%, Bio-Rad, 4561085 or 4561083) and resolved proteins transferred onto nitrocellulose membrane (0.45 μm, Bio-Rad, 9004-70-0). Membranes were exposed to the following antibodies: chicken anti-MAP2 (1:1000, Abcam, ab5392), mouse anti-TuJ1 (1:1000, Biolegend, 801202), rabbit anti-phosphorylated MYPT1 (Thr853; 1:1000, Cell Signaling, 4156), rabbit anti-MYPT1 (1:1000, Cell Signaling, 2634) or mouse anti-β-actin (1:10000, Sigma, A1978). Fluorescent secondary antibodies used were goat anti-chicken IgG conjugated to Alexa Fluor 647 (1:5000, Life Technologies, A21449) or goat anti-mouse IgG conjugated to Alexa Fluor 488 (1:5000, Life Technologies, A11029). Fluorescence was detected with a ChemiDoc MP Imaging System (Bio-Rad) and quantified using ImageJ software. HRP-conjugated secondary antibodies used were goat anti-mouse IgG (1:5000, Sigma, A4416) and goat anti-rabbit IgG (1:5000, Sigma, A6154), and were detected using ECL prime detection reagent (Amersham, RPN2232).

Cell projection quantification using NeuriteTracer

Images of neurite-like projection formation were obtained as described above and subject to image analysis using the NeuriteTracer plugin for ImageJ (Fiji) (Pool et al., 2008). Threshold parameters were defined using the vehicle cells. The TuJ1- or MAP2-stained CPL (in μm) was calculated as follows: total projection outgrowth length (all cells) divided by the number of (DAPI-stained) nuclei. For CPL quantification, five different images (technical replicates) were analyzed per treatment for each independent experiment. On average, each image encompassed ∼40 cells.

LPA treatment and Matrigel network formation

Control and network phenotypes were established for 24 h with treatment of vehicle (H2O) or Y-27632 (20 μM) in cells seeded at a density of 10,000 per cm2. Control cells were next treated with oleoyl-L-α-lysophosphatidic acid sodium salt (LPA, 1 μM, Sigma, 22556-62-3). Network cells were subsequently treated with vehicle or LPA with and without Y-27632 (20 μM). After 8 h, cells were fixed for 15 min with 4% (w/v) PFA. Cells underwent staining for TuJ1, and CPL quantification was performed for each experiment on five images per condition using the NeuriteTracer ImageJ plugin.

GFP-expressing GBM1 cells were incubated in Matrigel droplets (Corning, 365234) (10,000 cells per droplet) with the addition of vehicle (H2O) or Y-27632 (20 μM). After 16 h, images were acquired using an EVOS digital inverted fluorescence microscope, and CPLs were quantified from four images per condition in each biological replicate using NeuriteTracer ImageJ plugin.

Network analysis

Cell connections were manually annotated from immunostained images of control- (H2O) and Y-27632-treated (20 μM) cells using ImageJ. Two cells were considered connected if their TuJ-positive projections overlapped in the images. This process yielded maps of cell association. These associations were subsequently converted into GraphML format using in-house software (convertGML, available on Github at https://github.com/alastair-droop/associationGML). Per node, the degree and betweenness statistics were generated from the cell association GraphML files using igraph (Csardi and Nepusz, 2006) and R (numerical analysis) software (R core team, 2018). Network measures were calculated using the mean of the individual node statistics for each map. A total of nine Con and ten iNet maps (representing biological replicates) were processed. GraphML files are available online at https://doi.org/10.6084/m9.figshare.7270511.v1.

Cell movement tracking

Cells were seeded at two distinct confluencies (>10, 75,000 cells per cm2 or <50%, 200,000 cells per cm2). Following 24 h treatment with vehicle (H2O) or Y-27632 (20 μM), cells were monitored using the IncuCyte ZOOM system. Images were taken every 30 min and cellular tracking was performed on 15 distinct cells per condition from the obtained videos tracing the nuclei as the ‘point of movement’ via ImageJ software analysis (http://rsb.info.nih.gov/ij).

Ca2+ signaling and Lucifer Yellow dye assays

GBM1 cells were treated with vehicle (H2O) or Y-27632 (20 μM) for 24 h to establish the Con and iNet cellular phenotypes. The following day, Fluo-3-AM (Thermo Fisher Scientific, F23915) was added to the cells and incubated for 30 min in the dark at room temperature. The cells were then washed with PBS and kept in the dark for an additional 30 min. Live-cell imaging was performed on a Zeiss LSM780 on a Zeiss Observer Z1 equipped with a Coherent Chameleon laser. Laser injury was performed using 100% of the Coherent Chameleon laser at 800 nm. Images were taken every 1.95 s. Video analysis was carried out using ImageJ software, and the Ca2+ peak intensity was determined by the quantification of fluorescence intensity in ten randomly chosen cells before and after laser damage per imaged field. The percentage of cells in the wave was assessed by counting the number of cells that had an increase in fluorescence intensity following laser injury in relation to the total number of cells per imaged field. The Fluo-3 transmission wave angle was assessed using the ImageJ ‘angle tool’. The number of cells that transmitted the Fluo-3 signal was determined in five independent experimental repeats.

For the dye-loading via scratch assays, the Con and iNet cellular phenotypes were established in GBM1 cells using vehicle (H2O) or Y-27632 (20 μM), respectively, and cells were rinsed with PBS before the addition of 0.05% Lucifer Yellow (Thermo Fisher Scientific, L1177). A scratch wound was induced on the cells using a pipette tip and the dye was left on the cells for 2 min, allowing for its uptake. The cells were then rinsed with PBS (superfluous dye removal) and incubated with GBM medium for 8 min. After that period, live-cell images were taken immediately on an A1R confocal microscope. Quantification of Lucifer Yellow transfer was carried out by determining the number of cells containing the dye as a proportion of the total number of cells in the imaged area. Five images from five independent experiments were analyzed (>500 cells per condition).

Mitochondria and lysosome live-cell staining and imaging

After establishing Con and iNet phenotypes in GBM1 cells using vehicle (H2O) or Y-27632 (20 μM) for 24 h, the lysosomes of the cells were stained using LysoTracker (50 nM, Thermo Fisher Scientific, L7528), and the mitochondria were stained using MitoTracker (25 nM, Thermo Fisher Scientific, M7512). LysoTracker incubation was for 2 h, while MitoTracker incubation was for 1 h. Subsequently, cells were fixed with 4% (w/v) PFA for 10 min. Images were obtained using an A1R confocal microscope. For quantification of organelles in projections, the total mitochondrial volume was defined by color threshold using ImageJ (default setting; color space, HSB). The percentage of organelles in neurites was calculated by defining the area of the projections using color thresholding and determining the percentage area of MitoTracker-positive signal in projections (ten images were analyzed per condition). For live-cell imaging, images were taken every 30 s, for a total of 20 min, using the Zeiss LSM780 on a Zeiss Observer Z1 microscope. Mitochondrial migration was assessed using ImageJ tracking software analysis, tracing four cells per imaging experiment utilizing four videos per condition.

Mitochondrial transfer assay

Mitochondria of GBM1 cells were fluorescently labeled by incubating cells for 2 h with MitoTracker Red (25 nM) before washout and seeding in a 1:1 co-culture with GFP-expressing GBM1 cells (harboring unlabeled mitochondria) at a total cell density of 10,000, 5000 or 2500 cells per cm2. Con and iNet phenotypes were established using vehicle (H2O) or Y-27632 (20 μM) for 24 h. Cells were subsequently fixed with 4% (w/v) PFA for 15 min. Images were taken using an EVOS digital inverted fluorescence microscope. By defining the area of GFP–GBM1 cells by color threshold using ImageJ (default setting; color space, HSB), the percentage area of MitoTracker-positive mitochondria could be determined per cell. For analysis, five images per condition were quantified, with >90 cells analyzed per condition. Confocal images were also taken using a Nikon A1R confocal microscope following staining with Alexa Fluor 647–Phalloidin (1:100, Invitrogen, A22287).

Radiation treatment and cellular assays comparing Con, Rev and iNet phenotypic conditions

For cell irradiation, 20,000 cells per cm2 were seeded, and Con, Rev and iNet phenotypes were established in GBM1 cells via vehicle (H2O) exposure, Y-27632 addition (20 μM) for 24 h, while ‘washout’ (compound withdrawal) was carried out after 16 h of Y-27632 treatment. Subsequently, cells were irradiated with 0, 2, 8 and 20 Gy using the RadSource RS2000 irradiator

For cell behavior profiling of irradiated Con, Rev and iNet GBM1 cells, live-cell imaging was carried out immediately after radiation treatment using the IncuCyte ZOOM system. Five Con, Rev and iNet cells were tracked for each experimental condition (0, 2, 8 and 20 Gy) for 3 days in three independent experiments, hence yielding 15 individually traced cell behaviors per condition. An observation matrix was created by assessing each of the cells against the following five questions. (1) Does the monitored cell possess elongated neurite-like projections? (2) Is the monitored cell visually connected to other cells via neurite-like projections? (3) Is the monitored cell motile (>10 μm/min for Con and Rev cells and >2.5 μm/min for iNet cells)? (4) Is the monitored cell multinucleated? (5) What is the observed cell fate for the monitored cell? The first four parameters were created as dichotomous variables (possible outcomes were ‘positive’ or ‘negative’). The fifth (cell fate) parameter encompassed the categories: ‘divided’ (cell division occurring during the observation period), ‘pre-division’ (no cell division occurring during the observation period), ‘cell cycle arrest’ (cells which attempted to undergo mitosis but failed in the attempt) and ‘cell death’ (indicated by cell rounding and detachment). A graphical representation of all observed cell behaviors was generated by producing a heat map.

For the measurement of nuclear:cytoplasmic ratios within a cell, regions of interest (ROIs) for the cytoplasmic area were defined by color thresholding using ImageJ (default setting; color space, HSB) and the percentage area was calculated. Nuclear damage was assessed on cells based on DAPI staining: nuclei presenting with multi- or micro-nucleation segments were considered fragmented. For each radiation condition (0, 2, 8 and 20 Gy), three independent experimental repeats were performed for Con, iNet and Rev cells. For each experimental repeat, ten images were analyzed per radiation condition and treatment.

For the cell viability assay, GBM1 cells were seeded at densities of 10,000 cells per well in white 96-well plates (Greiner bio-one, 655083), and subsequently, Con, Rev and iNet phenotypes were established (with the aforementioned treatments) and cells were subject to (0, 2, 8 and 20 Gy) radiation treatments. After 5 days, the CellTiter-Glo assay (Promega, G7572) was used, and following equilibration of reagents and cells to room temperature, 100 μl of CellTiter-Glo reagent was added to each and incubation was for 10 min in the dark. The luminescence signal was measured using a Mithras LB 940 plate reader.

Extracellular flux-based metabolic assessment of Con, Rev and iNet GBM1 cells was carried out 5 days after radiation treatments (0 and 20 Gy) using the Seahorse XF extracellular flux analyzer and protocols described previously (Pike Winer and Wu, 2014). Cells were trypsinized and seeded into the manufacturer's microplates at a density of 30,000 cells per well. Before analysis, the medium was replaced with XF base medium (Seahorse Bioscience, 102353-100) and transferred to a 37°C non-CO2 humidified incubator. For the ‘Mito stress test’, XF base medium was supplemented with glucose (25 mM, Sigma, G8769), sodium pyruvate (0.5 mM, Sigma, S8636) and L-glutamine (2 mM, Gibco, 35050-061). The final medium was adjusted to pH 7.4 and filtered using a 0.2 μM filter. Oligomycin (1 μM), FCCP (0.5 μM), antimycin and rotenone (0.5 μM) were injected according to the Mito stress test protocol (Seahorse Bioscience, 101848-400) and results were analyzed using Mito stress test kit protocols.

RNA-seq transcriptional profiling

RNA sequencing of GBM1 cells was performed under Rev and iNet conditions. Following a 24-h treatment with Y-27632 and 8 h washout, cells were subjected to 0 and 20 Gy. Five days following irradiation, total RNA was isolated from three biological replicates of the 0 and 20 Gy Rev and iNet conditions using RNeasy Mini kits following the manufacturer's instructions (Qiagen; 74106). The integrity and concentration of RNA were determined using Qubit® RNA Assay Kit in Qubit® 2.0 Fluorometer (Life Technologies, CA). A total amount of 3 μg RNA was used per condition for RNA sample preparation. Sequencing libraries were generated using the NEBNext® Ultra™ RNA Library Prep Kit for Illumina® (NEB) following the manufacturer's recommendations and index codes were added to attribute sequences to each sample. The clustering of the index-coded samples was performed on a cBot Cluster Generation System using HiSeq PE Cluster Kit cBot-HS (Illumina) according to the manufacturer's instructions. After cluster generation, the library preparations were sequenced on an Illumina Hiseq platform and 125 bp or 150 bp paired-end reads were generated. Sequenced reads were quality-processed and aligned, and differential expression analysis performed as described previously (Conway et al., 2015), with the exception that the alignment was to the hg38 human reference genome using STAR aligner (v2.2.1) (Dobin et al., 2013). Briefly, reads were trimmed to retain quality and adapters removed, aligned to the human genome and quantified prior to paired sample differential gene expression analysis across groups.

Statistical analysis

Statistical details are provided in the figure legends. Data were analyzed by means of a two-sided paired Student's t-test, one-way or two-way ANOVA (Microsoft Office Professional Plus 2013 package and/or GraphPad Prism software version 7.05), or the Mann–Whitney U-test (assessing data from several dynamic cellular measurements). Heatmap and volcano plot visualization was performed in Excel (Microsoft Office Professional Plus 2013 package). Network degree and betweenness statistics were generated using igraph (Csardi and Nepusz, 2006) and R numerical analysis (R core team, 2018) software.

We thank Mihaela Lorger and Anestis Tsakiridis for critical advice.

Author contributions

Conceptualization: B.d.S., E.S.P., R.K.M., M.S., G.M., H.W.; Methodology: B.d.S., B.K.I., E.S.P., A.D., L.F.S., J.M., J.W., M.S., P.J.O.; Software: A.D., L.F.S.; Validation: B.d.S., B.K.I., E.S.P., H.B.S.G., R.K.M., S.J.A., H.W.; Formal analysis: B.d.S., E.S.P., A.D.; Investigation: B.d.S., B.K.I., E.S.P., H.B.S.G., C.W., J.W., M.S., S.J.A., H.W.; Resources: H.W.; Data curation: A.D., L.F.S.; Writing - original draft: B.d.S., H.W.; Writing - review & editing: B.K.I., R.K.M., S.C.S., S.J.A., G.M., H.W.; Visualization: B.d.S., H.W.; Supervision: S.J.A., G.M., H.W.; Project administration: B.d.S., E.S.P., J.W., H.W.; Funding acquisition: H.W.

Funding

We acknowledge support from the Brain Tumour Research and Support across Yorkshire charity (including ‘The Ian Meek PhD studentship’) and the Medical Research Council (MR/J001171/1). R.K.M. acknowledges support from Candlelighters and A.D. acknowledges support from the UKRI Rutherford fellowship (MR/S00386X/1).

Data availability

Network analysis (GraphML) files are available online at https://doi.org/10.6084/m9.figshare.7270511.v1 and the software at https://github.com/alastair-droop/associationGML. The RNA-seq transcriptional profiling data has been deposited into The European Nucleotide Archive under accession number PRJEB26811.

Ahmed
,
Z.
,
Douglas
,
M. R.
,
John
,
G.
,
Berry
,
M.
and
Logan
,
A.
(
2013
).
AMIGO3 is an NgR1/p75 co-receptor signalling axon growth inhibition in the acute phase of adult central nervous system injury
.
PLoS ONE
8
,
e61878
.
Azzam
,
E. I.
,
Jay-Gerin
,
J.-P.
and
Pain
,
D.
(
2012
).
Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury
.
Cancer Lett.
327
,
48
-
60
.
Bao
,
S.
,
Wu
,
Q.
,
McLendon
,
R. E.
,
Hao
,
Y.
,
Shi
,
Q.
,
Hjelmeland
,
A. B.
,
Dewhirst
,
M. W.
,
Bigner
,
D. D.
and
Rich
,
J. N.
(
2006
).
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
.
Nature
444
,
756
-
760
.
Caino
,
M. C.
,
Chae
,
Y. C.
,
Vaira
,
V.
,
Ferrero
,
S.
,
Nosotti
,
M.
,
Martin
,
N. M.
,
Weeraratna
,
A.
,
O'Connell
,
M.
,
Jernigan
,
D.
,
Fatatis
,
A.
, et al. 
(
2013
).
Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells
.
J. Clin. Invest.
123
,
2907
-
2920
.
Caino
,
M. C.
,
Seo
,
J. H.
,
Aguinaldo
,
A.
,
Wait
,
E.
,
Bryant
,
K. G.
,
Kossenkov
,
A. V.
,
Hayden
,
J. E.
,
Vaira
,
V.
,
Morotti
,
A.
,
Ferrero
,
S.
, et al. 
(
2016
).
A neuronal network of mitochondrial dynamics regulates metastasis
.
Nat. Commun.
7
,
13730
.
Conway
,
C.
,
Graham
,
J. L.
,
Chengot
,
P.
,
Daly
,
C.
,
Chalkley
,
R.
,
Ross
,
L.
,
Droop
,
A.
,
Rabbitts
,
P.
and
Stead
,
L. F.
(
2015
).
Elucidating drivers of oral epithelial dysplasia formation and malignant transformation to cancer using RNAseq
.
Oncotarget
6
,
40186
-
40201
.
Csardi
,
G.
and
Nepusz
,
T.
(
2006
).
The igraph software package for complex network research. http://igraph.org
Interjournal
Complex Systems
,
1695
.
Davis
,
M. E.
(
2016
).
Glioblastoma: overview of disease and treatment
.
Clin. J. Oncol. Nurs.
20
,
S2
-
S8
.
da Silva
,
B.
,
Mathew
,
R. K.
,
Polson
,
E. S.
,
Williams
,
J.
and
Wurdak
,
H.
(
2018
).
Spontaneous glioblastoma spheroid infiltration of early-stage cerebral organoids models brain tumor invasion
.
SLAS Discov.
23
,
2472555218764623
.
Dergham
,
P.
,
Ellezam
,
B.
,
Essagian
,
C.
,
Avedissian
,
H.
,
Lubell
,
W. D.
and
McKerracher
,
L.
(
2002
).
Rho signaling pathway targeted to promote spinal cord repair
.
J. Neurosci.
22
,
6570
-
6577
.
Dobin
,
A.
,
Davis
,
C. A.
,
Schlesinger
,
F.
,
Drenkow
,
J.
,
Zaleski
,
C.
,
Jha
,
S.
,
Batut
,
P.
,
Chaisson
,
M.
and
Gingeras
,
T. R.
(
2013
).
STAR: ultrafast universal RNA-seq aligner
.
Bioinformatics
29
,
15
-
21
.
Doe
,
C.
,
Bentley
,
R.
,
Behm
,
D. J.
,
Lafferty
,
R.
,
Stavenger
,
R.
,
Jung
,
D.
,
Bamford
,
M.
,
Panchal
,
T.
,
Grygielko
,
E.
,
Wright
,
L. L.
, et al. 
(
2007
).
Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities
.
J. Pharmacol. Exp. Ther.
320
,
89
-
98
.
Drubin
,
D. G.
,
Feinstein
,
S. C.
,
Shooter
,
E. M.
and
Kirschner
,
M. W.
(
1985
).
Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors
.
J. Cell Biol.
101
,
1799
-
1807
.
el-Fouly
,
M. H.
,
Trosko
,
J. E.
and
Chang
,
C. C.
(
1987
).
Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication
.
Exp. Cell Res.
168
,
422
-
430
.
El Hallani
,
S.
,
Boisselier
,
B.
,
Peglion
,
F.
,
Rousseau
,
A.
,
Colin
,
C.
,
Idbaih
,
A.
,
Marie
,
Y.
,
Mokhtari
,
K.
,
Thomas
,
J.-L.
,
Eichmann
,
A.
, et al. 
(
2010
).
A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry
.
Brain
133
,
973
-
982
.
Fletcher
,
D.A.
and
Mullins
,
R.D.
(
2010
).
Cell mechanics and the cytoskeleton
.
Nature
463
,
485
-
492
.
Fournier
,
A. E.
,
Takizawa
,
B. T.
and
Strittmatter
,
S. M.
(
2003
).
Rho kinase inhibition enhances axonal regeneration in the injured CNS
.
J. Neurosci.
23
,
1416
-
1423
.
Francescone
,
R. A.
,
Faibish
,
M.
and
Shao
,
R.
(
2011
).
A Matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells
.
J. Vis. Exp.
7
,
3040
.
Fujita
,
Y.
and
Yamashita
,
T.
(
2014
).
Axon growth inhibition by RhoA/ROCK in the central nervous system
.
Front. Neurosci.
8
,
338
.
Garton
,
A. J.
,
Castaldo
,
L.
and
Pachter
,
J. A.
(
2008
).
Quantitative high-throughput cell-based assays for inhibitors of ROCK kinases
. In
Small Gtpases in Disease, part B
(
Eds W. E. Balch, C. J. Der and A. Hall
), pp.
491
-
500
.
Elsevier
.
Grossman
,
S. A.
and
Batara
,
J. F.
(
2004
).
Current management of glioblastoma multiforme
.
Semin. Oncol.
31
,
635
-
644
.
Huang
,
D. W.
,
Sherman
,
B. T.
and
Lempicki
,
R. A.
(
2009a
).
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
.
Nat. Protoc.
4
,
44
-
57
.
Huang
,
D. W.
,
Sherman
,
B. T.
and
Lempicki
,
R. A.
(
2009b
).
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
.
Nucleic Acids Res.
37
,
1
-
13
.
Ikenoya
,
M.
,
Hidaka
,
H.
,
Hosoya
,
T.
,
Suzuki
,
M.
,
Yamamoto
,
N.
and
Sasaki
,
Y.
(
2002
).
Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor
.
J. Neurochem.
81
,
9
-
16
.
Jackson
,
M. D. B.
,
Duran-Nebreda
,
S.
and
Bassel
,
G. W.
(
2017
).
Network-based approaches to quantify multicellular development
.
J. R. Soc. Interface
14
,
20170484
.
Jia
,
X.-F.
,
Ye
,
F.
,
Wang
,
Y.-B.
and
Feng
,
D.-X.
(
2016
).
ROCK inhibition enhances neurite outgrowth in neural stem cells by upregulating YAP expression in vitro
.
Neural Regen. Res.
11
,
983
-
987
.
King
,
H. O.
,
Brend
,
T.
,
Payne
,
H. L.
,
Wright
,
A.
,
Ward
,
T. A.
,
Patel
,
K.
,
Egnuni
,
T.
,
Stead
,
L. F.
,
Patel
,
A.
,
Wurdak
,
H.
, et al. 
(
2017
).
RAD51 is a selective DNA repair target to radiosensitize glioma stem cells
.
Stem Cell Reports
8
,
125
-
139
.
Kranenburg
,
O.
,
Poland
,
M.
,
van Horck
,
F. P. G.
,
Drechsel
,
D.
,
Hall
,
A.
and
Moolenaar
,
W. H.
(
1999
).
Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction
.
Mol. Biol. Cell
10
,
1851
-
1857
.
Kuo
,
L. J.
and
Yang
,
L.-X.
(
2008
).
Gamma-H2AX - a novel biomarker for DNA double-strand breaks
.
In Vivo
22
,
305
-
309
.
Maekawa
,
M.
,
Ishizaki
,
T.
,
Boku
,
S.
,
Watanabe
,
N.
,
Fujita
,
A.
,
Iwamatsu
,
A.
,
Obinata
,
T.
,
Ohashi
,
K.
,
Mizuno
,
K.
and
Narumiya
,
S.
(
1999
).
Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase
.
Science
285
,
895
-
898
.
Minta
,
A.
,
Kao
,
J. P.
and
Tsien
,
R. Y.
(
1989
).
Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores
.
J. Biol. Chem.
264
,
8171
-
8178
.
Newman
,
M. E. J.
(
2006
).
Modularity and community structure in networks
.
Proc. Natl. Acad. Sci. USA
103
,
8577
-
8582
.
Ohashi
,
K.
,
Nagata
,
K.
,
Maekawa
,
M.
,
Ishizaki
,
T.
,
Narumiya
,
S.
and
Mizuno
,
K.
(
2000
).
Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop
.
J. Biol. Chem.
275
,
3577
-
3582
.
Osswald
,
M.
,
Jung
,
E.
,
Sahm
,
F.
,
Solecki
,
G.
,
Venkataramani
,
V.
,
Blaes
,
J.
,
Weil
,
S.
,
Horstmann
,
H.
,
Wiestler
,
B.
,
Syed
,
M.
, et al. 
(
2015
).
Brain tumour cells interconnect to a functional and resistant network
.
Nature
528
,
93
-
98
.
Ostrom
,
Q. T.
,
Bauchet
,
L.
,
Davis
,
F. G.
,
Deltour
,
I.
,
Fisher
,
J. L.
,
Langer
,
C. E.
,
Pekmezci
,
M.
,
Schwartzbaum
,
J. A.
,
Turner
,
M. C.
,
Walsh
,
K. M.
, et al. 
(
2014
).
The epidemiology of glioma in adults: a “state of the science” review
.
Neuro Oncol.
16
,
896
-
913
.
Osuka
,
S.
and
Van Meir
,
E. G.
(
2017
).
Overcoming therapeutic resistance in glioblastoma: the way forward
.
J. Clin. Invest.
127
,
415
-
426
.
Piccirillo
,
S. G. M.
,
Reynolds
,
B. A.
,
Zanetti
,
N.
,
Lamorte
,
G.
,
Binda
,
E.
,
Broggi
,
G.
,
Brem
,
H.
,
Olivi
,
A.
,
Dimeco
,
F.
and
Vescovi
,
A. L.
(
2006
).
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
.
Nature
444
,
761
-
765
.
Pike Winer
,
L. S.
and
Wu
,
M.
(
2014
).
Rapid analysis of glycolytic and oxidative substrate flux of cancer cells in a microplate
.
PLoS ONE
9
,
e109916
.
Polson
,
E. S.
,
Kuchler
,
V. B.
,
Abbosh
,
C.
,
Ross
,
E. M.
,
Mathew
,
R. K.
,
Beard
,
H. A.
,
da Silva
,
B.
,
Holding
,
A. N.
,
Ballereau
,
S.
,
Chuntharpursat-Bon
,
E.
, et al. 
(
2018
).
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice
.
Sci. Transl. Med.
10
,
eaar2718
.
Pool
,
M.
,
Thiemann
,
J.
,
Bar-Or
,
A.
and
Fournier
,
A. E.
(
2008
).
NeuriteTracer: a novel ImageJ plugin for automated quantification of neurite outgrowth
.
J. Neurosci. Methods
168
,
134
-
139
.
Rath
,
N.
and
Olson
,
M. F.
(
2012
).
Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy
.
EMBO Rep.
13
,
900
-
908
.
Ross-Macdonald
,
P.
,
de Silva
,
H.
,
Guo
,
Q.
,
Xiao
,
H.
,
Hung
,
C.-Y.
,
Penhallow
,
B.
,
Markwalder
,
J.
,
He
,
L.
,
Attar
,
R. M.
,
Lin
,
T.
, et al. 
(
2008
).
Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors
.
Mol. Cancer Ther.
7
,
3490
-
3498
.
R core team
(
2018
).
R: a Language and Environment for Statistical Computing
.
Vienna Austria
:
R Foundation for Statistical Computing
.
Salhia
,
B.
,
Rutten
,
F.
,
Nakada
,
M.
,
Beaudry
,
C.
,
Berens
,
M.
,
Kwan
,
A.
and
Rutka
,
J. T.
(
2005
).
Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1
.
Cancer Res.
65
,
8792
-
8800
.
Sanz-Moreno
,
V.
,
Gaggioli
,
C.
,
Yeo
,
M.
,
Albrengues
,
J.
,
Wallberg
,
F.
,
Viros
,
A.
,
Hooper
,
S.
,
Mitter
,
R.
,
Féral
,
C. C.
,
Cook
,
M.
, et al. 
(
2011
).
ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma
.
Cancer Cell
20
,
229
-
245
.
Straight
,
A. F.
,
Cheung
,
A.
,
Limouze
,
J.
,
Chen
,
I.
,
Westwood
,
N. J.
,
Sellers
,
J. R.
and
Mitchison
,
T. J.
(
2003
).
Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor
.
Science
299
,
1743
-
1747
.
Subramanian
,
A.
,
Tamayo
,
P.
,
Mootha
,
V. K.
,
Mukherjee
,
S.
,
Ebert
,
B. L.
,
Gillette
,
M. A.
,
Paulovich
,
A.
,
Pomeroy
,
S. L.
,
Golub
,
T. R.
,
Lander
,
E. S.
, et al. 
(
2005
).
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
.
Proc. Natl. Acad. Sci. USA
102
,
15545
-
15550
.
Tilson
,
S. G.
,
Haley
,
E. M.
,
Triantafillu
,
U. L.
,
Dozier
,
D. A.
,
Langford
,
C. P.
,
Gillespie
,
G. Y.
and
Kim
,
Y.
(
2015
).
ROCK inhibition facilitates in vitro expansion of glioblastoma stem-like cells
.
PLoS ONE
10
,
e0132823
.
Torralba
,
D.
,
Baixauli
,
F.
and
Sánchez-Madrid
,
F.
(
2016
).
Mitochondria know no boundaries: mechanisms and functions of intercellular mitochondrial transfer
.
Front. Cell Dev. Biol.
4
,
107
.
Weil
,
S.
,
Osswald
,
M.
,
Solecki
,
G.
,
Grosch
,
J.
,
Jung
,
E.
,
Lemke
,
D.
,
Ratliff
,
M.
,
Hänggi
,
D.
,
Wick
,
W.
and
Winkler
,
F.
(
2017
).
Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas
.
Neurooncology
19
,
1316
-
1326
.
Winkler
,
F.
and
Wick
,
W.
(
2018
).
Harmful networks in the brain and beyond
.
Science
359
,
1100
-
1101
.
Wharton
,
S. B.
,
Chan
,
K. K.
and
Whittle
,
I. R.
(
2002
).
Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas
.
J. Clin. Neurosci.
9
,
165
-
169
.
Wurdak
,
H.
(
2012
).
Exploring the cancer stem cell phenotype with high-throughput screening applications
.
Future Med. Chem.
4
,
1229
-
1241
.
Wurdak
,
H.
,
Zhu
,
S.
,
Romero
,
A.
,
Lorger
,
M.
,
Watson
,
J.
,
Chiang
,
C.-Y.
,
Zhang
,
J.
,
Natu
,
V. S.
,
Lairson
,
L. L.
,
Walker
,
J. R.
, et al. 
(
2010
).
An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation
.
Cell Stem Cell
6
,
37
-
47
.
Zohrabian
,
V. M.
,
Forzani
,
B.
,
Chau
,
Z.
,
Murali
,
R.
and
Jhanwar-Uniyal
,
M.
(
2009
).
Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation
.
Anticancer Res.
29
,
119
-
123
.

Competing interests

The authors declare no competing or financial interests.

Supplementary information